Scholar Rock Holding Corporation (SRRK) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 5.14B USD. 52-week range 27.07 to 61.76 USD. Data as of 2026-10-09.
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. The company's novel understanding of the molecular mechanisms of growth factor activation within the transforming growth factor beta (TGFß) superfamily has enabled the development of a proprietary platform. This platform is used for the development of monoclonal antibodies that ...